A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen

Clinical trial NCT02105987 · COMPLETED

Trial details

NCT number: NCT02105987
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2014-04-01
Primary completion: 2015-04-01
Enrollment: 555

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.